BioStock: BiBBInstruments’ cancer study comes to early end after convincing data
BiBBInstruments’ first clinical study with EndoDrill Model X in deep tumours of the upper gastrointestinal tract has been completed earlier than expected after an interim analysis showed that the objective of the study has been achieved already in seven out of the planned 20 patients. Preliminary results indicate that the product safely enables effective sampling of core biopsies when examined with endoscopic ultrasound. After this success, the company is now awaiting further results from its second clinical trial, EDUX02, which is expected to be completed later this year.
Read the article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se